A pharmaceutical company from the UK GlaxoSmithKline will use artificial intelligence to create medicines. Its executives signed a contract with the organization Exscientia, which creates these technologies.

At present, pharmacists are increasingly interested in attracting artificial intelligence to the procedure for developing medical medicines. British pharmaceutical producer GlaxoSmithKline soon intends to use these technologies in its business. The company entered into an agreement with Exscientia, which specializes in creating the above innovations. The deal amounted to 43 million dollars.

Now experts are engaged in research of the potential use of artificial intelligence in the field of creating drugs, vladtime.ru reports. Scientists use the latest powerful computers and machine learning mechanisms to anticipate the likelihood of production of drugs. So pharmacists do not want to conduct additional experiments to save their money and time.

© All rights reserved. Citing to www.ict.az is necessary upon using news